Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

Authors: Jakko van Ingen, Timothy R. Aksamit, C. Andréjak, Erik C. Böttger, Emmanuelle Cambau, Charles L. Daley, David E. Griffith, Lorenzo Guglielmetti, Steven M. Holland, Gwen A. Huitt, Won‐Jung Koh, Christoph Lange, Philip Leitman, Theodore K. Marras, Kozo Morimoto, Kenneth N. Olivier, Miguel Santín, Jason E. Stout, Rachel Thomson, Enrico Tortoli, Richard J. Wallace, Kevin Winthrop, Dirk Wagner - European Respiratory Journal 2018 cited by 263

Nontuberculous mycobacterial pulmonary diseases (NTM-PD) are increasingly recognised as opportunistic infections of humans. These chronic pulmonary infections have two main presentations. The first is a fibro-cavitary disease, that occurs in patients with pre-existing pulmonary diseases, such as chronic obstructive pulmonary disease, bronchiectasis, previous tuberculosis or other structural lung disease. The second presentation is a nodular-bronchiectatic disease of primarily the lingula and middle lobe that tends to affect a middle-aged and elderly female population [1]. Improving treatment outcome reporting in NTM disease: NTM-NET (@ntmnet) consensus statement on treatment outcome definitions <http://ow.ly/c6IC30iwLM4> The authors wish to thank the American Thoracic Society, European Respiratory Society, Infectious Diseases Society of America and European Society of Clinical Microbiology and Infectious Diseases for organising the two meetings during which the process leading to this statement was initiated. These organisations do not officially endorse this NTM-NET consensus statement.